Virchow Biotech Pvt, Ltd.
Virchow Biotech Pvt. Ltd. is a global leader in biopharmaceuticals, specializing in high-quality biogenerics, pharmaceuticals, medical devices, and active pharmaceutical ingredients (APIs). Established in 2001 in Hyderabad, India, the company is ISO 13485:2016 and WHO-GMP certified, with a presence in over 100 countries. With over 24 years of operational experience, Virchow Biotech is committed to innovation, quality, and delivering life-saving therapies worldwide. The company has expanded its global footprint with offices in the USA and is working towards providing affordable healthcare solutions through cutting-edge research and manufacturing.
Industries
Nr. of Employees
large (251-1000)
Virchow Biotech Pvt, Ltd.
Plot No 319, 320, 3rd floor, East Avenue, Swamy Ayappa Society, Madhapur, Hyderabad, India – 500081.
Patents
Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
US-10688249-B2
View Details
Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
US-10688249-B2
View DetailsProducts
Advanced wound care therapeutics and dressings
Topical gels, creams and antimicrobial dressings for burns, pressure injuries, diabetic foot ulcers and chronic wounds, including growth-factor gels, silver-based antimicrobials, iodine-based products and lyophilized wound matrix sheets.
Sterile anticoagulant injectables (fondaparinux, enoxaparin, heparin)
Parenteral anticoagulant products in prefilled syringes, cartridges and vials intended for prevention and treatment of venous thromboembolism and related cardiovascular indications.
Recombinant endocrine therapeutics (parathyroid hormone/teriparatide)
Recombinant parathyroid hormone (teriparatide) supplied in prefilled liquid cartridges or injectables for osteoporosis treatment.
Aesthetic dermal fillers (hyaluronic acid injectable formulations)
Cross-linked hyaluronic acid dermal fillers supplied as prefilled syringes for soft-tissue augmentation and wrinkle reduction.
Probiotic formulations and oral biologics
Probiotic products and spore suspensions formulated for management of diarrheal disorders and restoration of intestinal flora in various dosage forms (ampoules, sachets, capsules).
Plasma- and serum-derived therapeutics and antisera
Lyophilized and liquid formulations of equine-derived antiserum for envenomation and rabies passive immunization, supplied as vials.
Advanced wound care therapeutics and dressings
Topical gels, creams and antimicrobial dressings for burns, pressure injuries, diabetic foot ulcers and chronic wounds, including growth-factor gels, silver-based antimicrobials, iodine-based products and lyophilized wound matrix sheets.
Sterile anticoagulant injectables (fondaparinux, enoxaparin, heparin)
Parenteral anticoagulant products in prefilled syringes, cartridges and vials intended for prevention and treatment of venous thromboembolism and related cardiovascular indications.
Recombinant endocrine therapeutics (parathyroid hormone/teriparatide)
Recombinant parathyroid hormone (teriparatide) supplied in prefilled liquid cartridges or injectables for osteoporosis treatment.
Aesthetic dermal fillers (hyaluronic acid injectable formulations)
Cross-linked hyaluronic acid dermal fillers supplied as prefilled syringes for soft-tissue augmentation and wrinkle reduction.
Probiotic formulations and oral biologics
Probiotic products and spore suspensions formulated for management of diarrheal disorders and restoration of intestinal flora in various dosage forms (ampoules, sachets, capsules).
Plasma- and serum-derived therapeutics and antisera
Lyophilized and liquid formulations of equine-derived antiserum for envenomation and rabies passive immunization, supplied as vials.
Services
Third-party manufacturing for tablets, sterile injectables and finished dosage forms with project governance, KPI monitoring, quality planning and risk assessment.
Third-party manufacturing for tablets, sterile injectables and finished dosage forms with project governance, KPI monitoring, quality planning and risk assessment.
Expertise Areas
- Biogeneric and recombinant therapeutic development
- Biologics and sterile injectable manufacturing
- Contract manufacturing and CMO services
- Advanced wound care products and biomaterials
Key Technologies
- Recombinant protein expression and formulation
- PEGylation
- Lyophilization of biologics
- Sterile injectable fill-finish (vials, prefilled syringes, cartridges, auto-injectors)
News & Updates
Introduction of new probiotic strains and wound care products like SCARAZE and CADEXOMER IODINE.
Certifications from EN ISO 13485:2016, USFDA, WHO-GMP, and approvals from Brazil, Columbia, and Canada.
A detailed overview of the company's focus on research, manufacturing, and global impact.
Successfully developed and commercialized multiple biogenerics and biosimilars, with a global presence in over 100 countries.
Introduction of new probiotic strains and wound care products like SCARAZE and CADEXOMER IODINE.
Certifications from EN ISO 13485:2016, USFDA, WHO-GMP, and approvals from Brazil, Columbia, and Canada.
A detailed overview of the company's focus on research, manufacturing, and global impact.
Successfully developed and commercialized multiple biogenerics and biosimilars, with a global presence in over 100 countries.